From [email protected] <[email protected]>
Subject Drugnet Issue 81
Date May 3, 2022 12:36 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Web Version: [link removed]
-----------------------
=================
Welcome
=================
Drug use among students in higher education in Ireland
by Seán Millar
The use of illicit drugs is a public health issue worldwide with the annual prevalence of drug use
increasing over the past decade. International research from Ireland, the United Kingdom, and the
United States suggests that approximately one-quarter of students in higher education institutes
(HEIs) report using illicit drugs within the last 12 months. However, there is a lack of recent
comprehensive data on drug use among students in higher education in the Republic of Ireland.

[link removed]
=================
Policy
=================
Sexual violence related to alcohol and/or drug use among Irish students
by Anne Doyle
In 2021, a national survey was carried out among 7,901 students and 3,516 staff to monitor the
experiences of students and staff in relation to sexual violence and harassment in higher education
institutions (HEIs) in Ireland and their awareness and confidence in HEI policies, processes, and
initiatives in the area.1,2

[link removed]
-----------------------------------
Joint Committee on Health and the national drugs strategy
by Lucy Dillon
In Ireland, the Joint Committee on Health scrutinises the work of the Department of Health and its
agencies. It is responsible for examining health policy, the future planning of health services, and
proposed changes to the way in which healthcare is delivered.1 Membership includes representation
from the Dáil and the Seanad.2

On 19 January 2022, the Minister of State for Public Health, Wellbeing and the National Drugs
Strategy, Frank Feighan TD, came before the committee to provide an update on the national drugs
strategy. He was supported by Dr Eamon Keenan, the national clinical lead for the Health Services
Executive’s (HSE) addiction services, and Jim Walsh, principal officer at the Drugs Policy and
Social Inclusion Unit at the Department of Health.

[link removed]
-----------------------------------
Industry influence over global alcohol policies via the World Trade Organization: a qualitative
analysis of discussions on alcohol health warning labelling, 2010–2019
by Anne Doyle
Evidence of the harms caused by alcohol consumption globally, including the three million annual
deaths worldwide,1 has encouraged national governments to commit to strategies to reduce
alcohol-related harms. These include those set out in the World Health Organization (WHO) 2010
Global strategy to reduce the harmful use of alcohol2 and the 2030 Sustainable Development Goals as
well as through the development of the WHO Global alcohol action plan.3 It is well-recognised that
policies to control the harms associated with alcohol consumption need to be instituted at national
level to be effective; however, national governments face resistance and opposition from the alcohol
industry when attempting to implement such policies. Common arguments by the alcohol industry when
lobbying against such policies are that they are not required and are expensive to implement.
Instead, it proposes alternatives, including information campaigns and a focus on subpopulations
only, such as those pregnant, young people, or drink drivers. In its efforts to influence
decision-making, the alcohol industry often questions the legality and effectiveness of proposed
interventions and the extent of alcohol-related harms, citing the benefits of moderate consumption.

[link removed]
=================
In brief
=================
Like many contentious social issues, positions on drug policy are often aligned with political
outlooks. While what are described as cultural issues have blurred the traditional dividing line
between left and right, we can still speak about coherent political philosophies. Politics, at least
in the developed world, can be understood as competition between liberal and conversative world
outlooks. Liberals comprise two camps: one libertarian, which is liberal on economic issues and
protective of individual liberty; and one which is social democratic, also keen to guard personal
freedoms but in favour of an interventionist state to offset the consequences of market failures.
Conservatives emphasise the value of stability and see government’s role as supporting societal
anchors such as the family, personal responsibility, self-reliance, and respect for tradition.
Personal freedom is an essential aspect of conservative philosophy, but the state has the right to
intervene to prevent behaviour deemed harmful to the individual or the community.

[link removed]
=================
Recent research
=================
Exploring grief within the family system following a drug-related death of a family member
by Claire Erraught
Drug-related deaths (DRDs) are a growing burden,1 with limited international evidence of the impact
of grief and the lived experience of an affected family. DRDs are associated with moral stigmas,
emotional burden, shame, guilt, and complicated grief from ‘a loss that cannot be socially
sanctioned, openly acknowledged or publicly mourned’.2 Evidence suggests there is a need for
targeted interventions in this population to explore the complex grief experienced. A 2021 study
investigated the impact of complicated grief on the family system following the DRD of a family
member from an Irish context.3

[link removed]
-----------------------------------
Treating alcohol withdrawal syndrome with baclofen in opioid-dependent patients
by Claire Erraught
Patients prescribed opioid agonist therapy (OAT) for opioid dependence are known to have increased
risk of multiple substance addiction, including alcohol.1 Benzodiazepines are commonly used to treat
alcohol withdrawal syndrome (AWS); however, given their sedative effects, increased risk of misuse,
and accidental overdose, an alternative therapy is warranted for OAT patients undergoing alcohol
detoxification. Baclofen is an emerging treatment for alcohol detoxification as it can reduce the
craving to drink and can suppress AWS symptoms. Currently, there is a lack of evidence for its
effectiveness in OAT patients. A 2021 study therefore investigated baclofen’s effectiveness and
patient acceptability in treating AWS in OAT patients.2

[link removed]
-----------------------------------
Consumer protection messages in alcohol marketing on Twitter in Ireland: a content analysis
by Anne Doyle
The prevalence of alcohol use disorder among the general population in Ireland is estimated at
14.8%.1 In an attempt to reduce alcohol consumption in Ireland and consequently the rate of
alcohol-related harms, the Public Health (Alcohol) Act was enacted in 2018.2 Several components of
the Act have been commenced but a number remain outstanding, such as Section 13. Section 13 of the
Act will restrict the content of alcohol advertisements, requiring the marketing of alcohol products
to contain facts about the dangers associated with alcohol consumption; how its use is linked to a
number of cancers; how unsafe it is to consume during pregnancy; and will include a link to an
independent website containing public health information about alcohol.

[link removed]
-----------------------------------
Comparing characteristics of suicide to non-suicide drug poisoning deaths, by sex, in Ireland
by Ena Lynn
A new study has been published based on Irish data comparing characteristics of suicide to
non-suicide drug poisoning deaths (NSDPD), by sex.1 Both suicide deaths and drug poisoning deaths
are dominated by deaths among men; therefore, absence of sex-stratified mortality data can mask
important sex-based differences in the data.

[link removed]
=================
Prevalence
=================
Trends in alcohol and drug admissions to psychiatric facilities
by Seán Millar
In 2020, some 958 cases were admitted to psychiatric facilities with an alcohol disorder, of whom
382 were treated for the first time. Figure 1 presents the rates of first admission between 2000 and
2020 for cases with a diagnosis of an alcohol disorder. The admission rate in 2020 was higher than
the previous year, although trends over time indicate an overall decline in first admissions.
Approximately one-third (33.3%) of cases hospitalised for an alcohol disorder in 2020 stayed just
under 1 week, while 32.7% of cases were hospitalised for between 1 and 3 months, similar to previous
years.

[link removed]
-----------------------------------
Healthcare professional wellbeing impacted by Covid-19 while supporting clients with addiction in
Ireland
by Claire Erraught
The Covid-19 pandemic impeded the delivery of addiction support services to this high-risk group as
existing healthcare models were dramatically altered or abolished. The impact of the pandemic
negatively affected addiction recovery, with adverse health outcomes and drug-related mortality seen
to increase, in turn impacting the wellbeing of practitioners already under pressure.1 A 2022 study
explored the impact that the pandemic had on the wellbeing of Irish healthcare professionals
supporting clients with addiction.2

[link removed]
-----------------------------------
Rising alcoholic liver disease hospital admissions and deaths in Irish hospitals, 2007–2016: a
retrospective cross-sectional analysis
by Anne Doyle
In 2017, the per capita alcohol consumption in Ireland equated to every Irish adult (aged 15 years
and over) drinking 13.9 litres of alcohol, considerably higher than the 6.5 litres globally.1
Alcohol-related harms are associated with this level of alcohol consumption, with the period from
1995 to 2013 seeing an 82% increase in alcohol-related hospital admissions in Ireland.2,3 Alcoholic
liver disease (ALD) is caused by damage to the liver from excessive drinking over a prolonged
period, and treatment involves alcohol abstinence, managing complications of liver failure, and/or
liver transplantation. ALD is a major cause of both liver cirrhosis and hepatocellular carcinoma
(HCC), a type of primary liver cancer.

[link removed]
=================
Responses
=================
Overview of case management related to work with people who use drugs
by Suzi Lyons
Internationally, case management (CM) was first adapted in the 1980s to work with people who use
drugs; however, the concept had emerged first in the 1920s.1 In 2010, the Health Service Executive
(HSE) published the National Drugs Rehabilitation Framework Document,2 in which CM was outlined as a
key component. This framework was in response to the earlier policy document, Report of the Working
Group on Drugs Rehabilitation,3 which recommended ‘a framework through which service providers will
ensure that individuals affected by drug misuse are offered a range of integrated options tailored
to meet their needs and create for them an individual rehabilitation pathway.

[link removed]
-----------------------------------
The experience of Chrysalis Drug Project in providing case management
by Suzi Lyons
Chrysalis is a community drug and alcohol service which has been operating for almost 25 years in
Dublin’s north inner city.1,2 The service has grown significantly since then, especially in more
recent years; having started as a counselling service it has moved on to provide a range of other
services. Its vision is that ‘everyone living with problem substance use should be empowered to
fulfil their full potential and have access to the same opportunities and rights as others’.3

[link removed]
-----------------------------------
Gender-specific services for women experiencing homelessness and addiction
by Lucy Dillon
In September 2021, Merchants Quay Ireland (MQI) launched a briefing paper calling for governmental
support to provide gender-specific services for women experiencing homelessness and addiction,
entitled A space of her own: the need for gender specific services for women in homelessness and
addiction.1 The briefing paper draws on the findings of a number of studies, in particular
Responding to women with complex needs who use substances, which was published in 2020.2

[link removed]
-----------------------------------
The needs of people who use drugs and are aged 40+ years
by Lucy Dillon
People who use drugs (PWUD) and are aged 40 years or over experience particular challenges as a
cohort. These include social isolation and exclusion as well as poorer physical and mental health
outcomes.1 The Ballyfermot Local Drug and Alcohol Task Force (BLDATF) commissioned a study on the
needs of this cohort in their area of Dublin. Entitled It’s like we’re the forgotten...: an
exploration of the issues affecting older people in Ballyfermot who are experiencing problematic
drug and alcohol use, it was published in March 2021.1

[link removed]
-----------------------------------
Merchants Quay Ireland annual review, 2020
by Seán Millar
Merchants Quay Ireland (MQI) is a national voluntary agency providing services for homeless people
and those that use drugs. There are 22 MQI locations in 12 counties in the Republic of Ireland (see
Figure 1). MQI aims to offer accessible, high-quality, and effective services to people dealing with
homelessness and addiction in order to meet their complex needs in a non-judgemental and
compassionate way. This article highlights services provided by MQI to people who use drugs in
Ireland in 2020.1

[link removed]
-----------------------------------
Ana Liffey Drug Project annual report, 2020
by Seán Millar
The Ana Liffey Drug Project (ALDP) is a ‘low-threshold, harm reduction’ project working with people
who are actively using drugs and experiencing associated problems. ALDP has been offering harm
reduction services to people in the north inner-city area of Dublin since 1982, from premises at
Middle Abbey Street. ALDP offers a wide variety of low-threshold, harm reduction services that
provide pathways for people who use drugs out of their current circumstance, including addiction and
homelessness.

[link removed]
=================
Recent publications
=================
[link removed]----------------------
This email was sent to [email protected] from [email protected]

Unsubscribe:
[link removed]

Report Misuse: [link removed]
Change Email Format (Text/HTML):
[link removed]
Screenshot of the email generated on import

Message Analysis